Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction

https://doi.org/10.1016/0014-2999(96)00291-9Get rights and content

Abstract

Ergoline-derived dopamine receptor agonists, like pergolide or bromocryptine, have recently attracted attention as potential neuroprotective drugs. The classical mixed type dopamine D1 and D2 receptor agonist apomorphine, although used clinically in the therapy of Parkinson's disease, has never been examined for any properties related to neuroprotection. In this paper, we examine the effects of 0.1–100 μM apomorphine on ascorbate/iron-stimulated free radical processes in rat brain mitchondrial fraction. Lipid peroxidation as assayed by the thiobarbituric acid reaction can be completely inhibited by submicromolar concentrations of apomorphine (0.3 μM with 2.5 μM Fe2+ and 0.6 μM with 5.0 μM Fe2+), which proved to be more than twice as effective as desferrioxamine and twenty times as compared with dopamine. The inhibition of lipid peroxidation in mitochondria correlates with an increased rate of apomorphine oxidation. The formation of protein carbonyls, which is generally less sensitive to antioxidants, could be significantly reduced by apomorphine. In the model system we employed, apomorphine was more active than dopamine, desferrioxamine, or pergolide in preventing the formation of thiobarbituric reactive substances. The time course of the reaction suggests that apomorphine acts as a radical scavenger and that its iron chelating properties may not be of major importance. Since oxidative stress has been implicated in Parkinson's disease, the role of apomorphine as a neuroprotective is worthy of examination.

References (37)

  • N.E. Tolbert

    Isolation of subcellular organelles in isopycnic sucrose gradients

    Methods Enzymol.

    (1974)
  • G.L. Wenk et al.

    Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat

    Brain Res.

    (1994)
  • W. Zhao et al.

    An in vitro EPR study of the free-radical scavenging actions of the lazaroid antioxidants U-74500A and U-78517F

    Free Radic. Biol. Med.

    (1995)
  • D. Ben-Shachar et al.

    Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease

    J. Neurochem.

    (1991)
  • P.H. Chan

    Oxygen radicals in focal cerebral ischemia

    Brain Pathol.

    (1994)
  • S. Fahn et al.

    The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

    Ann. Neurol.

    (1992)
  • J.P. Frankel et al.

    Subcutaneous apomorphine in the treatment of Parkinson's disease

    J. Neurol. Neurosurg. Psychiatry

    (1990)
  • S.T. Gancher et al.

    Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of tolerance

    Mov. Disord.

    (1995)
  • Cited by (128)

    • Myricitrin attenuates 6-hydroxydopamine-induced mitochondrial damage and apoptosis in PC12 cells via inhibition of mitochondrial oxidation

      2013, Journal of Functional Foods
      Citation Excerpt :

      Mitochondrial protein quantification was determined by the Bradford method (Bradford, 1976) using BSA as standard. Lipid peroxidation was determined by the formation of thiobarbituric acid reactive substances (TBARS) as described and modification (Gassen, Glinka, Pinchasi, & Youdim, 1996). Briefly, rat brain mitochondria 100 μg/well in 0.2 M histidine buffer including FeSO4 50 μM and cystine 500 μM was added into 96-well plate.

    View all citing articles on Scopus
    View full text